GTCM
VCYT icon

Gyon Technologies Capital Management’s Veracyte VCYT Stock Holding History

Gyon Technologies Capital Management’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-20,031
Closed -$333K – 616
2022
Q3 		$333K Buy
+20,031
New +$451K 0.1% 233

Other funds holding VCYT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Gyon Technologies Capital Management's VCYT Position: Q4 2022 in Review

Gyon Technologies Capital Management sold out of Veracyte (VCYT) in Q4 2022, closing a stake of 20,031 shares — an estimated $333K sold.

Gyon Technologies Capital Management first reported a position in VCYT in Q3 2022 and held it in 1 quarter. The position peaked at $333K in Q3 2022. 223 funds tracked by Wall St. Rank hold VCYT as of Q4 2022.

  • Gyon Technologies Capital Management reported no remaining Veracyte position as of Q4 2022 after selling out during the quarter.
  • Gyon Technologies Capital Management sold 20,031 Veracyte shares in Q4 2022, an estimated $333K.
  • Gyon Technologies Capital Management first reported a position in Veracyte in Q3 2022 and held it in 1 quarter.
  • Gyon Technologies Capital Management's Veracyte position peaked at $333K in Q3 2022.
  • 223 funds tracked by Wall St. Rank held Veracyte as of Q4 2022.

Based on Gyon Technologies Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.